Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody–drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study

Jian Zhang, Ruifeng Liu, Shixuan Wang, Zhe Feng, Huazhe Yang, Shan Gao, X Li, Xueqing Yao, Jie Chen, Z. Gong, Yafei Li, X Li, Shixuan Wang, Caixia Hu, Jingjing Liu, M. Zhang, Fei Yuan, Ben Shi, Hanmei Lou, Peng Zhao, Feng-Fang Qiu, Hanxu Guo, Bo Hu, Danfeng Xu, Huiyi Huang, Xiao Zhang, Mei Feng, Xianlong Wang, Guiling Li, D. Liu, Daniel Chen, Peng Wang